Pfizer management check

PFE · Health Care · Pharmaceuticals · CEO Bourla

Filings as of

63
Management score, ranked 277th of 487 · 30th of 60 in Health Care5 good · 1 to watch · 1 flaggedStrongest: clean books · Weakest: owner returns · Best and worst run in Health Care →

The seven checks

  • Flag

    Have owners done well?

    Trailed its chosen peersOwners$86Peers$187

    What $100 became since fiscal 2021

    016th
    Detail

    $100 invested at the start of fiscal 2021 grew to $86, against $187 for the peer group the company picked itself.

  • Good

    Does pay follow performance?

    Pay rose and fell with returns20212025

    Pay actually paid $100 value, each on its own scale

    7842nd
    Detail

    Over 5 years, the CEO's pay actually paid (equity valued at the share price) had a correlation of 0.57 with shareholder return. 1 means pay moved in step; below 0, the opposite way.

  • Good

    What does the CEO cost owners?

    0.4% of net income

    $27.6m pay · $7.8bn net income, FY2025

    0.1%1%3%10%
    8785th
    Detail

    $27.6m of reported pay in fiscal 2025, against $7.8bn of net income.

  • Good

    Do they own the stock?

    Insiders are buying

    429,173 shares ≈ $11.3m

    0.1y1y5y20y100y

    6 mo: ▲ $3.0m bought · ▼ $135k sold

    3637th
    Detail

    The CEO holds 429,173 shares, directly or through trusts (unvested awards not counted): about 0.4 years of pay. 3 insiders bought $3.0m on the open market in the last six months, with their own money, near the lows. Sales: $135k.

  • Watch

    Are owners being diluted?

    Share count growing2021 · 5.7bn2025 · 5.7bn

    Diluted shares +0.0% a year; flagged above +2%

    0%10%20%

    Stock pay 1.3% of revenue

    5034th
    Detail

    Diluted shares changed +0.0% a year over the last three fiscal years. Stock-based pay was 1.3% of revenue in the latest year.

  • Good

    Is leadership stable?

    7 leadership filings in 3 years

    7 filings under 8-K 5.02 in 3 years

    0101420+

    CEO: Bourla

    9069th
    Detail

    CEO in the pay table: Bourla. 7 filings under 8-K item 5.02 (officers or directors leaving or joining, or new pay arrangements) in the last 3 years.

  • Good

    Are the books clean?

    No red flags on file

    Since 2021

    • 0Restated
    • 0Auditor changes
    • 0Late filings
    • 010-K amended
    100100th
    Detail

    No restatements, auditor changes or late filings since 2021.

  • Reading the scores

    Each check scored 0–100 from its own figure. The tick is the Health Care median; the ordinal is the share of ranked S&P 500 companies it matches or beats.

    Hover a chart for its figures. Detail has the full reading.

Pay versus performance

From the proxy statement filed March 12, 2026.

CEO pay as reportedActually paid ⓘWhat $100 becamePeer group the company chose
−$62.1m$26.5m$115.2m$10020212022202320242025$86$187

Pay tied most to Adjusted Net Income

Other key measuresTotal RevenueAdjusted Diluted EPSCash Flow from Operations

Show the figures
Fiscal yearCEOCEO payActually paidOther executives (avg)$100 becamePeersNet income
2025Bourla$27.6m$33.7m$9.6m$86$187$7.8bn
2024Bourla$24.6m$38.5m$8.5m$86$151$8.0bn
2023Bourla$21.6m−$62.1m$6.3m$88$143$2.1bn
2022Bourla$33.0m$5.7m$14.8m$149$133$31.4bn
2021Bourla$24.4m$115.2m$9.3m$167$123$22.0bn

Insiders and the CEO's stakeBuying

Chairman & CEO
Albert Bourla
Shares held
429,173
At that filing's price
≈ $11.3m
Latest Form 4
Aug 12, 2026

3 insiders bought $3.0m on the open market in the last six months, with their own money, near the lows. Sales: $135k.

Open-market trades by officers and directors since May 21, 2026.

  • BoughtAlbert BourlaChairman & CEO$1.0mAug 12, 2026
  • BoughtRonald E BlaylockDirector$999kAug 5, 2026
  • BoughtMortimer J BuckleyDirector$960kAug 5, 2026
  • SoldJennifer B. DamicoSVP & Controller$135kAug 5, 2026

Leadership and governance on file

20222023202420252026Leadership 11Votes 5
All 11 filings

Latest shareholder vote results: Apr 27, 2026, including the say-on-pay vote.

Where the money went

2021–2025: $2.0bn returned to owners in buybacks and dividends, 3% of net income, and $4.3bn of pay in stock.

Net incomeBuybacksDividendsStock-based payDiluted shares
$0$15.7bn$31.4bn20212022202320242025Shares5.71bn5.73bn5.71bn5.70bn5.71bn
Show the figures
Fiscal year20212022202320242025
Revenue$73.6bn$91.8bn$50.9bn$63.6bn$62.6bn
Net income$22.0bn$31.4bn$2.1bn$8.0bn$7.8bn
Stock-based pay$1.2bn$872.0m$525.0m$877.0m$799.0m
Buybacks$0$2.0bn$0$0—
Dividends—————
Diluted shares5708m5733m5709m5700m5713m

Educational only, not investment advice. Figures are as filed with the SEC: pay from the proxy's pay-versus-performance table, capital allocation from 10-K XBRL data, insider trades from Form 4s over the last six months, events from the last 5 years of filings. The peer group is the one the company chose. See the method.